MEA Surgical Sutures Market Size

Middle East and Africa Surgical Sutures Market Overview

The Middle East and Africa surgical sutures market size was valued at USD 0.4 Billion in 2022. The surgical sutures industry is projected to grow from USD 0.42 Billion in 2023 to USD 0.68 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% during the forecast period (2023 - 2032).The increasing number of surgical procedures, the launch of advanced sutures with growth in personalized medications and the rise in lifestyle diseases due to the increasing adoption of a sedentary lifestyle are the key market drivers enhancing the market growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Middle East and Africa Surgical Sutures Market Trends

• The growing number of surgical procedures is driving the market growth

Market CAGR for surgical sutures is driven by an increasing number of knee replacements, hip replacements, hysterectomies, bypass surgeries, and cosmetic surgeries, which are elevating the use of this device to close wounds quicker. Also, the rapidly increasing geriatric population is increasing the demand and adoption of surgical sutures due to the increasing incidence of surgical procedures such as joint replacement, angioplasty, and organ transplant among elderly patients. This is leading to higher demand for advanced devices in healthcare settings in this region. For instance, according to a study issued by the National Centre for Biotechnology Information, it was observed that around 30.0% of aged people fall due to difficulty walking every year, leading to a rising number of patients undergoing knee replacement surgeries.

Additionally, growing awareness about advanced surgical interventions has propelled the market players to focus strongly on R&D and launch new and innovative products in the market. Additionally, the rapid influx of new and automated sutures with improved features has led to a growing preference of surgeons towards these devices in this region. The market's growth is further augmented by advancements in material and tip of the suture, which has revolutionized the suturing procedure during surgery. Increasing usage of advanced materials by manufacturers, which are biocompatible and are prominent in reducing the healing time of the wound, has led to higher demand and adoption of surgical sutures in the market.

Furthermore, wound closure with surgical sutures is a crucial challenge for flexible endoscopic surgeries. The use of synthetic biomaterials as basic materials for surgical sutures, such as poly (lactic-co-glycolic acid) or polydioxanone, is a result of recent advancements in functional materials. The layers of tissues, tension, tissue type, surgical access, and time of removal play a role in choosing suture materials for wound closure. The kind of wound closure decides using absorbable or non-absorbable materials for sutures. While non-absorbable sutures degrade poorly in the bodily tissues, absorbable sutures typically lose around 50% of their tensile strength within 60 days in the tissues where they are either digested by an enzyme or hydrolyzed. Certain non-absorbable sutures, such as steel for closing the sternum or bone, might remain in the body forever. Hence, manufacturers focusing on developing advanced sutures are expected to drive the surgical sutures market revenue.

Middle East and Africa Surgical Sutures Market Segment Insights

Middle East and Africa Surgical Sutures Product Type Insights

The Middle East and Africa surgical sutures market segmentation, based on product type, includes absorbable and non-absorbable. The absorbable segment dominated the market, accounting for 35% of market revenue (0.15 Billion). In developing economies, category growth is driven by its ability to temporarily support wounds until it heals and can withstand normal stress. However, non-absorbable is the fastest-growing category due to its inability to degrade or break down. These sutures are majorly used in stressful internal environments where absorbable sutures cannot fulfill the desired requirement.

Middle East and Africa Surgical Sutures Raw Material Insights

The Middle East and Africa surgical sutures market segmentation, based on the raw material, includes natural and synthetic. The synthetic category generated the most income (70.4%) owing to the comparatively lower incidence of hypersensitivity reactions using synthetic sutures during wound closure. However, natural is the fastest-growing category due to its nature to react with tissues after wound closure, driving the market growth for surgical sutures.

Middle East and Africa Surgical Sutures Construction Insights

The Middle East and African surgical sutures market segmentation, based on construction, includes single filament and multi-filament. The single filament segment dominated the market, accounting for major market revenue as it has a positively low cost and minimal tissue reaction due to its smooth surface. However, multi-filament is the fastest-growing category due to advantages associated with the multi-filament segment, such as better pliability, high tensile strength, and flexibility.

Figure 1: Middle East and Africa Surgical Sutures Market, by Construction, 2022 & 2032 (USD Billion) 

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Middle East and Africa Surgical Sutures Countries Insights

By countries, the study provides market insights into GCC, South Africa and the Rest of MEA. The GCC surgical sutures market will dominate owing to the presence of local and key players, the high cost of sutures compared to other regions, the supportive reimbursement scenario, rising government programs, and developed healthcare infrastructure.

Figure 2: MIDDLE EAST AND AFRICA SURGICAL SUTURES MARKET SHARE BY COUNTRIES 2022 (USD Billion) 

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South Africa's surgical sutures market accounts for the second-largest market share due to the growing geriatric population base that is more likely to go under surgery and the increase in government spending on healthcare infrastructure to meet the unmet needs in this region. Moreover, major players are operating in this country, and an increasing need for mRNA vaccines and therapeutics drives market growth.

The Rest of the MEA surgical sutures market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to the increasing prevalence of gynecological and cardiovascular diseases resulting in an increasing number of surgery procedures, rising awareness for advanced surgical devices, and the focus of the major players in emerging countries.

Surgical Sutures Key Market Players & Competitive Insights

Major market players are investing heavily in R&D to expand their product lines, which will help the Surgical Sutures market grow even more. Market participants are also undertaking several strategic activities to enhance their footprint, with important market developments including unique product launches, contractual agreements, higher investments, mergers and acquisitions, and collaboration with other firms. To enhance and survive in a more competitive and growing market climate, the Surgical Sutures industry must deliver cost-effective items.

Manufacturing locally to minimize operational price is one of the key business tactics manufacturers in the Middle East and Africa Surgical Sutures industry use to benefit clients and enhance the market sector. The Surgical Sutures industry has offered some of the most significant medical advantages in recent years. Major players in the Surgical Sutures market, including Valneva SE, Takeda Pharmaceutical Company Limited, Abbott, AstraZeneca, Sanofi, Pfizer Inc., Janssen Global Services, LLC, and others, are attempting to enhance market demand by investing in research and development operations.

Olympus Corp is a company that produces precise machinery and instruments for optics and digital technology. The company develops, manufactures and commercializes equipment and devices for medical, imaging, healthcare, information, and other industrial markets. It delivers medical systems, including endoscopes and endoscopy, and therapy devices, products to help healthcare professionals treat patients, and scientific solutions, such as laser scanning microscopes, industrial and biological microscope systems, remote visual inspection products and non-destructive testing systems. It also delivers biomedical materials and system development services. In October 2022, Olympus Corporation launched THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery in South Africa. THUNDERBEAT Open Fine Jaw Type X is a new thermal shield, a surgical energy device designed to support safer procedures.

Smith & Nephew Plc is a medical technology firm engaged in developing, manufacturing, and marketing medical devices for use in sports medicine, orthopedic reconstruction and trauma, ENT and advanced wound management. The company offers knee and hip implants to replace diseased, damaged, or worn joints; robotics-assisted technologies; and trauma-related products to stabilize fractures and deformity correction procedures. It also offers products and instruments to repair and remove soft tissue and wound care products. Smith & Nephew offers its products to surgeons; nurses and nurse specialists; physicians and general practitioners; and purchasing professionals in hospitals and healthcare insurers. In September 2020, Smith & Nephew launched its HEALICOIL KNOTLESS Suture Anchor. With this, the company aimed to grow its revolutionary line of advanced healing solutions for rotator cuff repair.

Key Companies in the Surgical Sutures market include

• 
  

  Johnson & Johnson Inc.

  
  


• 
  

  Braun Melsungen AG

  
  


• 
  

  Smith & Nephew PLC

  
  


• 
  

  Ethicon Inc

  
  


• 
  

  Demetech Corporation

  
  


• 
  

  Conmed Corporation

  
  


• 
  

  W.L. Gore & Associates

  
  


• 
  

  Sutures India Pvt. Ltd

  
  


• 
  

  Boston Scientific Corporation

  
  


• 
  

  Dolphin Sutures

  
  


• 
  

  3M Healthcare

  
  


• 
  

  Medtronic Inc.

  
  


• 
  

  DemeTECH Corporation

  
  

Surgical Sutures Industry Developments

October 2022:Alameda Healthcare Group launched the center of excellence for minimally invasive and robotics surgery in collaboration with Cambridge Medical Robotics Systems (CMR), elevating Egypt’s healthcare sector and revolutionizing surgical procedures by introducing CMR’s latest innovative technology, the Versius robotic surgical system.

July 2022:Tygerberg Public Hospital, Capetown, South Africa, used the da Vinci Xi robot to assist in removing a cancerous tumor from a female patient. It is the only robot used in South Africa. This platform is currently used for the hospital's complex urological, gynecological, and colorectal surgical procedures. Such technologically advanced products contribute to the growth of the studied market in the country.

April 2021:Dolphin Sutures, a global leader in surgical sutures, announced the launch of non- absorbable polytetrafluoroethylene (PTFE) suture. PTFE is very strong, knots well, and is biologically inert.

Middle East and Africa Surgical Sutures Market Segmentation

Middle East and Africa Surgical Sutures Product Type Outlook

• 
  

  Absorbable

  
  


• 
  

  Non-Absorbable

  
  

Middle East and Africa Surgical Sutures Raw Material Outlook

• 
  

  Natural

  
  


• 
  

  Synthetic

  
  

Middle East and Africa Surgical Sutures Construction Outlook

• 
  

  Single Filament

  
  


• 
  

  Multi Filament

  
  

Middle East and Africa Surgical Sutures Countries Outlook

• 
  

  Middle East

  
  
  
  
  • 
    

     GCC

    
    
  
  
  • 
    

    South Africa

    
    
  
  
  • 
    

    Rest of MEA